Cube Biotech Acquires IBA Lifesciences GmbH

Bruker Corporation Acquires biocrates life sciences ag

June 3, 2025

Biotechnology

Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.

BBI Solutions Acquires IBEX Technologies Inc.

April 8, 2024

Biotechnology

BBI Solutions OEM Limited has acquired IBEX Technologies Inc., a Montreal-based developer and manufacturer of high-precision enzymes and diagnostic solutions, with the transaction closing on April 8, 2024. The acquisition expands BBI's recombinant protein and enzyme capabilities to better serve in-vitro diagnostics (IVD) manufacturers and brings IBEX's staff and contract-manufacturing capabilities into BBI's global operations.

ImmunoPrecise Antibodies Acquires Belgian BioStrand, BioKey and BioClue

April 14, 2022

Biotechnology

ImmunoPrecise Antibodies Ltd. (IPA), through its subsidiary ImmunoPrecise Netherlands BV, completed the acquisition of BioStrand BV, BioKey BV and BioClue BV, a group of Belgian bioinformatics and biotech companies. The deal (approx. €20 million consideration plus up to €12 million earnout and a €6 million investment commitment) adds AI-driven multi-omics analytics and software capabilities to IPA's antibody discovery and biotherapeutics platform.

ARCHIMED Acquires Majority Stake in Cube (Cube Biotech)

November 3, 2021

Biotechnology

Transatlantic healthcare private equity firm ARCHIMED has purchased a majority stake in Monheim, Germany-based Cube (Cube Biotech), a specialist provider of high-purity, stable membrane proteins for drug discovery. ARCHIMED will support Cube's US market expansion and broaden its product and service offering organically and via acquisitions while Cube's founding management remain significant shareholders and continue to lead the business.

ArchiMed Acquires ImaBiotech and Pyxant Labs; Pyxant Acquires LabCorp/Covance Salt Lake City Site

July 6, 2021

Healthcare Services

European healthcare-focused private equity firm ArchiMed completed three simultaneous transactions to create a market leader in bioanalytical services: it acquired French molecular-imaging and bioanalysis specialist ImaBiotech and Colorado Springs-based Pyxant Labs, while Pyxant also acquired LabCorp/Covance's Salt Lake City bioanalytical and oligonucleotide studies site. The combined moves expand ArchiMed's capabilities and North American footprint in bioanalytical testing for clinical trials.

Tecan Group Acquires IBL International

July 30, 2014

Medical Devices

Tecan Group (SIX: TECN) has acquired IBL International, a Hamburg-based specialist in microtiter plate immunoassays, for EUR 29.0 million in cash. IBL will join Tecan’s Life Sciences Business to enable integrated instrument-plus-reagent solutions for specialty diagnostics, supporting Tecan’s shift toward higher recurring revenues.